MedTrace Logo

Candidate Gene Association Study With Injury in Elite Male Youth Football Players

NCT04952662 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 123

Last updated 2021-07-07

No results posted yet for this study

Summary

Understanding how candidate genes, previously associated with injury susceptibility, influence the incidence of muscle, bone, ligament, and tendon injuries across the development pathway of elite footballers may provide valuable insight into inherent injury predisposition to support the long-term development of every individual. Therefore, the aim of the present study was to investigate the association between candidate genetic variants and muscle, bone, ligament, and tendon injuries in elite football with sub-analysis of the influence of age and maturation on injury susceptibility.

Conditions

  • Injuries
  • Genetic Change

Interventions

GENETIC

Genetic variants

COL1A1 rs1800012, COL1A2 rs412777, COL5A1 rs12722, ACTN3 rs1815739, ACE rs1799752, ESR1 rs2234693, MMP3 rs679620, VDR rs2228570 and GDF5 rs143383

Sponsors & Collaborators

  • Fulham Football Club

    collaborator UNKNOWN

  • St Mary's University College

    lead OTHER

Eligibility

Min Age
8 Years
Max Age
40 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-12-01
Primary Completion
2021-05-31
Completion
2021-05-31
FDA Drug
Yes

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04952662 on ClinicalTrials.gov